The NIH is offering the Pediatric Immunotherapy Discovery and Development Network Grant to establish collaborative centers aiming to advance immunotherapy for children and adolescents with cancer. This grant aligns with the Beau Biden Cancer Moonshot Initiative and the Blue Ribbon Panel’s scientific priority of creating a pediatric immunotherapy translational science network. The grant focuses on discovering new immunotherapy targets, developing pediatric immunotherapy treatments, and understanding how pediatric tumors evade the immune system. Applications are due by Dec 17, 2018.
Opportunity ID: 308195
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-19-003 |
| Funding Opportunity Title: | Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U54 – Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.353 — 21st Century Cures Act – Beau Biden Cancer Moonshot |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 13, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Dec 17, 2018 |
| Current Closing Date for Applications: | Dec 17, 2018 |
| Archive Date: | Jan 22, 2019 |
| Estimated Total Program Funding: | $2,500,000 |
| Award Ceiling: | $1,600,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments City or township governments County governments Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) For profit organizations other than small businesses Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to establish centers of collaborating investigators with the goal of identifying and advancing research opportunities for translating immunotherapy concepts for children and adolescents with cancer toward clinical applications. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Recommendation (B) that calls for the establishment of a pediatric immunotherapy translational science network. The network was envisioned by the BRP as focusing on identifying new targets for immunotherapies, developing new pediatric immunotherapy treatment approaches (e.g., cancer vaccines, cellular therapy, combinations of immunotherapy agents, and others), and defining the biological mechanisms by which pediatric tumors evade the immune system. The Pediatric Immunotherapy Discovery and Development Network (PI-DDN) Centers will address and implement these BRP recommendations. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-003.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | FORMS-E | PKG00244400 | Nov 01, 2018 | Dec 17, 2018 | View |
Package 1
Mandatory forms
308195 RR_SF424_2_0-2.0.pdf
308195 PHS398_CoverPageSupplement_4_0-4.0.pdf
308195 RR_OtherProjectInfo_1_4-1.4.pdf
308195 PerformanceSite_2_0-2.0.pdf
308195 RR_KeyPersonExpanded_2_0-2.0.pdf
308195 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
308195 PHS_Additional_IndirectCosts-1.0.pdf
308195 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
